Statistics
Publications
61
Citations
14.1K
H-Index
35
Active since
1988
Langdon L. Miller is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and oncology.
Publications per year
1988–2021
61
61
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Leonard B. Saltz, John V. Cox, Charles D. Blanke et al. · New England Journal of Medicine · 2000 · 3K citations · Full text
Medicine, Oncology, Pharmacology +13
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
Richard R. Furman, Jeff P. Sharman, Steven Coutré et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text
PTC124 targets genetic disorders caused by nonsense mutations
Ellen Welch, Elisabeth R. Barton, Jin Zhuo et al. · Nature · 2007 · 1.1K citations
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
Ajay K. Gopal, Brad S. Kahl, Sven de Vos et al. · New England Journal of Medicine · 2014 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +17
Caio M. Rocha Lima, Mark R. Green, Robert Rotche et al. · Journal of Clinical Oncology · 2004 · 586 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 61